瘤病毒改变了瘤细胞外囊泡的生物发生,并影响了它们的免疫性
Ugo Hirigoyen1,2, Coraly Guilbaud1,2, Morgane Krejbich1,2
1Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, 44000 Nantes, France.
Molecular therapy. Oncology
|November 4, 2024
概括
瘤病毒 (OVs) 促进瘤细胞分泌细胞外囊泡 (EVs). 这些病毒修饰的EV携带病毒蛋白质,增强细胞间通信,并可能增强抗瘤免疫力.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 细胞生物学 细胞生物学
背景情况:
- 细胞外囊泡 (EVs) 是瘤微环境通信的关键,影响转移,免疫抑制和耐药性.
- 病毒感染通常会增加EV分泌,但瘤病毒 (OVs) 对瘤EVs的影响在很大程度上仍未被探索.
研究的目的:
- 调查瘤囊泡性口腔炎病毒 (VSV) 和疫苗病毒如何影响由人类黑色素瘤和胸部癌细胞分泌的EV.
- 了解OV修饰瘤EVs的特征和功能影响.
主要方法:
- 人类黑色素瘤和胸部癌细胞感染VSV和疫苗病毒.
- 分析分泌的EVs,包括蛋白质组分析和蛋白质转移的评估.
- 用OV感染的EV化CD8+T细胞,以评估细胞毒性功能.
主要成果:
- OV感染显著增加了瘤细胞的EV产生.
- 感染OV的EV (EVs-OV) 含有病毒蛋白 (例如VSV-G),模糊了EV和病毒之间的界限.
- 在EVs-OV上的VS-G促进了增强的蛋白质转移到其他瘤微环境细胞.
- EVs-OV被丰富了与免疫相关的蛋白质.
- 暴露于EVs-OV的CD8+ T细胞显示出略有增强的细胞毒性活性.
结论:
- OVs在瘤微环境中增强了EV介导的通信.
- 经过OV修改的EV可能有助于OVs的治疗效果.
- 这些发现支持OVs的工程,以利用EVs进行向的治疗性蛋白质输送.
相关概念视频
Tumor Immunotherapy
484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Vaccines
341
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
341
Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Mechanisms of Retrovirus-induced Cancers
5.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K


